Plea for psychedelic rules reform A new coalition of healthcare professionals wants a review of ‘overly restrictive’ prescribing guidelines, but a GP expert says changes must be done ‘slowly and carefully’.
Ketamine effective for treatment-resistant depression: Study New Australian-led research shows a 10-fold treatment advantage for the drug compared with placebo.
Psychedelic prescribing to begin for PTSD and depression Experts are split on whether Australia is prepared for psychedelic-assisted therapy, but GPs need to be ready to answer questions and refer patients.
MDMA and psilocybin: What GPs need to know A TGA decision about the use of psychedelics has attracted much attention, and criticism. Dr Hester Wilson offers guidance on fielding patient queries.
Therapeutic psychedelics: Mental health ‘magic bullet’ or expensive trip? Interest continues to grow in the use of psychedelics to treat a variety of mental health conditions, but there is disagreement over whether existing research supports their wider use.